Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

PR-51

Alternative Names: pr-51, pr51, pr 51
Latest Update: 2023-09-01
Latest Update Note: PubMed Publication

Product Description

Diphtheria and Tetanus toxoids and acellular Pertussis adsorbed, inactivated Poliovirus, Haemophilus b conjugate [meningococcal outer membrane protein complex], and Hepatitis B [recombinant] vaccine

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Coagulation Factor

Route of Administration: Intramuscular

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Merck
Company Location: KENILWORTH NJ 07033
Company CEO: Robert M. Davis
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Tetanus|Hepatitis B|Diphtheria|Influenza, Human|Poliomyelitis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
V419-002

P2

Completed

Influenza, Human|Hepatitis B|Tetanus|Diphtheria

2003-03-01

V419-003

P2

Completed

Hepatitis B|Diphtheria|Tetanus|Influenza, Human|Poliomyelitis

2003-01-01

Recent News Events

Date

Type

Title

09/01/2023

PubMed

 Dipicolinic acid enhances kiwifruit resistance to Botrytis cinerea by promoting phenolics accumulation.

01/01/2021

PubMed

 The effect of new acrylic full removable dentures on food taste.

01/01/2020

PubMed

 Stress in the bone and prosthetic components due to "all-on-4" system with polyether-ether-ketone screwing prosthesis. Analysis using 3D finite element method.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions